DOW JONES22,679.99+1627.46 7.73%
S&P 5002,663.68+175.03 7.03%
NASDAQ7,913.24+540.16 7.33%

Barclays Initiates Coverage On Deciphera Pharmaceuticals with Overweight Rating, Announces $70 Price Target

Barclays analyst Peter Lawson initiates coverage on Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Overweight rating and a $70 price target.

Benzinga · 03/04/2020 10:24

Barclays analyst Peter Lawson initiates coverage on Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Overweight rating and a $70 price target.